Showing results (1711-1720 of 2,670) with videos related to

Sort By:
Pageof 267
Bioorganic & Medicinal Chemistry|November 23, 2006
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonistsFrank W Foss, Ashley H Snyder, Michael D Davis, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 30, 2021
A quantitative systems pharmacology modeling platform for evaluating triglyceride profiles in patients with high triglycerides receiving evinacumabMasood Khaksar Toroghi, Jim Bosley, Lyn M Powell, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
K252a is a potent and selective inhibitor of phosphorylase kinaseL H Elliott, S E Wilkinson, A D Sedgwick, et al.
BJU International|October 17, 2013
Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costsAnthony D Ta, Damien M Bolton, Margaret K Dimech, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 27, 2015
Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approachNathalie L Maitre, Roberta A Ballard, Jonas H Ellenberg, et al.
JAMA Ophthalmology|January 4, 2014
Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36Emily Y Chew, Traci E Clemons, Elvira Agrón, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 17, 2025
Population Pharmacokinetics and Exposure-Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial HypercholesterolemiaSébastien Bihorel, Robert Dingman, Jeanne Mendell, et al.
Pediatrics|September 1, 2023
Defining and Promoting Pediatric Pulmonary Health: Assessing Lung Function and StructureEmily M DeBoer, Wayne J Morgan, Lesliam Quiros-Alcala, et al.
Pageof 267